Victory Capital Management
PROK icon

Victory Capital Management’s ProKidney PROK Stock Holding History

Victory Capital Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.2K Sell
11,828
-321
-3% -$681 ﹤0.01% 2375
2025
Q4 		$27.2K Buy
12,149
+715
+6% +$1.88K ﹤0.01% 2368
2025
Q3 		$27.7K Buy
11,434
+560
+5% +$1.49K ﹤0.01% 2381
2025
Q2 		$6.44K Sell
10,874
-205
-2% -$160 ﹤0.01% 2473
2025
Q1 		$9.71K Sell
11,079
-317
-3% -$440 ﹤0.01% 2456
2024
Q4 		$19.3K Buy
+11,396
New +$20.5K ﹤0.01% 2447

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management's PROK Position: Q1 2026 in Review

Victory Capital Management reduced its ProKidney (PROK) stake by 2.6% in Q1 2026, selling an estimated $681 and leaving 11,828 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2375.

Victory Capital Management first reported a position in PROK in Q4 2024 and has held it in 6 quarters since. The position peaked at $27.7K in Q3 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Victory Capital Management held 11,828 shares of ProKidney worth $21.2K as of Q1 2026.
  • Victory Capital Management sold 321 ProKidney shares in Q1 2026, an estimated $681.
  • ProKidney made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2375 holding.
  • Victory Capital Management first reported a position in ProKidney in Q4 2024 and has held it in 6 quarters since.
  • Victory Capital Management's ProKidney position peaked at $27.7K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.